{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:57:33Z","timestamp":1792447053620,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1136\/ijgc-2018-000042","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T14:11:48Z","timestamp":1547475108000},"page":"113-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Clinicopathologic characteristics, tumor infiltrating lymphocytes and programed cell death ligand-1 expression in 162 endometrial carcinomas with deficient mismatch repair function"],"prefix":"10.1016","volume":"29","author":[{"given":"Jesus A","family":"Chavez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian A","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil V","family":"Parwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaibo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2018-000042_bb0010","first-page":"3607","article-title":"Methylation of hMLH1 in a population-based series of endometrial carcinomas","volume":"6","author":"Salvesen","year":"2000","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1136\/ijgc-2018-000042_bb0015","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1158\/0008-5472.CAN-06-1114","article-title":"Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients","volume":"66","author":"Hampel","year":"2006","journal-title":"Cancer Res"},{"key":"10.1136\/ijgc-2018-000042_bb0020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9440(10)63994-6","article-title":"Histopathological identification of colon cancer with microsatellite instability","volume":"158","author":"Alexander","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1136\/ijgc-2018-000042_bb0025","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00000478-200305000-00001","article-title":"Phenotype of microsatellite unstable colorectal carcinomas: well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability","volume":"27","author":"Greenson","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1136\/ijgc-2018-000042_bb0030","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1002\/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.0.CO;2-U","article-title":"Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma","volume":"91","author":"Smyrk","year":"2001","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2018-000042_bb0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.gastro.2007.04.044","article-title":"Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study","volume":"133","author":"Jenkins","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1136\/ijgc-2018-000042_bb0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1472-6890-13-33","article-title":"Efficient and reproducible identification of mismatch repair deficient colon cancer: validation of the MMR index and comparison with other predictive models","volume":"13","author":"Joost","year":"2013","journal-title":"BMC Clin Pathol"},{"key":"10.1136\/ijgc-2018-000042_bb0045","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.humpath.2007.05.022","article-title":"Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer","volume":"39","author":"Shia","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1136\/ijgc-2018-000042_bb0050","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jamaoncol.2015.2151","article-title":"Association of polymerase e-mutated and microsatellite-instable endometrial cancers with neoantigen load, number of tumor-infiltrating lymphocytes, and expression of PD-1 and PD-L1","volume":"1","author":"Howitt","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1136\/ijgc-2018-000042_bb0055","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/modpathol.2014.143","article-title":"Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations","volume":"28","author":"Hussein","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1136\/ijgc-2018-000042_bb0060","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1158\/1078-0432.CCR-15-0057","article-title":"POLE proofreading mutations elicit an antitumor immune response in endometrial cancer","volume":"21","author":"van Gool","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1136\/ijgc-2018-000042_bb0065","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/igc.0000000000001120","article-title":"Programmed death ligand 1 expression among 700 consecutive endometrial cancers: strong association with mismatch repair protein deficiency","volume":"28","author":"Li","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2018-000042_bb0070","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-13-3271","article-title":"Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy","volume":"20","author":"Taube","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1136\/ijgc-2018-000042_bb0075","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/gcc.20854","article-title":"Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer","volume":"50","author":"Vaughn","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"issue":"15_suppl","key":"10.1136\/ijgc-2018-000042_bb0080","article-title":"Clinicopathological and molecular parameters of lung adenocarcinomas (ADC) associated with programmed cell death ligand 1 (PD-L1) protein expression","volume":"33","author":"Huynh","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2018-000042_bb0085","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"10.1136\/ijgc-2018-000042_bb0090","doi-asserted-by":"crossref","first-page":"341","DOI":"10.5858\/arpa.2015-0506-SA","article-title":"Programmed death ligand-1 immunohistochemistry - a new challenge for pathologists: a perspective from members of the Pulmonary Pathology Society","volume":"140","author":"Sholl","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1136\/ijgc-2018-000042_bb0095","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.lungcan.2015.01.016","article-title":"Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: comparison with tumor-infiltrating T cells and the status of oncogenic drivers","volume":"88","author":"Kim","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1136\/ijgc-2018-000042_bb0100","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/modpathol.2015.63","article-title":"Clinicopathologic analysis of programmed cell death-1 and programmed cell death-ligand 1 and 2 expressions in pulmonary adenocarcinoma: comparison with histology and driver oncogenic alteration status","volume":"28","author":"Koh","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1136\/ijgc-2018-000042_bb0105","doi-asserted-by":"crossref","first-page":"14209","DOI":"10.18632\/oncotarget.3694","article-title":"The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs","volume":"6","author":"Tang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1136\/ijgc-2018-000042_bb0110","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2018-000042_bb0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1158\/2159-8290.CD-14-0863","article-title":"The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints","volume":"5","author":"Llosa","year":"2015","journal-title":"Cancer Discov"},{"key":"10.1136\/ijgc-2018-000042_bb0120","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1053\/j.gastro.2008.01.015","article-title":"Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers","volume":"134","author":"Schwitalle","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1136\/ijgc-2018-000042_bb0125","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ygyno.2017.07.003","article-title":"Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival","volume":"146","author":"Cosgrove","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000042_bb0130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability","volume":"96","author":"Umar","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-2018-000042_bb0135","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/cncr.21560","article-title":"Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma","volume":"106","author":"Broaddus","year":"2006","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2018-000042_bb0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1066896909332117","article-title":"Lynch syndrome - related endometrial carcinomas show a high frequency of nonendometrioid types and of high FIGO grade endometrioid types","volume":"18","author":"Carcangiu","year":"2010","journal-title":"Int J Surg Pathol"},{"key":"10.1136\/ijgc-2018-000042_bb0145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"key":"10.1136\/ijgc-2018-000042_bb0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2014.05.006","article-title":"POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium","volume":"134","author":"Meng","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2018-000042_bb0155","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/PAP.0000000000000161","volume":"24","author":"Hendry","year":"2017","journal-title":"Adv Anat Pathol"},{"key":"10.1136\/ijgc-2018-000042_bb0160","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2018-000042_bb0165","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/modpathol.2016.117","article-title":"Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas","volume":"29","author":"Scheel","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1136\/ijgc-2018-000042_bb0170","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1158\/0008-5472.CAN-12-2384","article-title":"Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma","volume":"73","author":"Lyford-Pike","year":"2013","journal-title":"Cancer Res"},{"key":"10.1136\/ijgc-2018-000042_bb0175","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1097\/PAS.0000000000000698","article-title":"Programmed death-ligand 1 expression is common in gastric cancer associated with Epstein-Barr virus or microsatellite instability","volume":"40","author":"Ma","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1136\/ijgc-2018-000042_bb0180","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/modpathol.2009.80","article-title":"Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations","volume":"22","author":"Tougeron","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1136\/ijgc-2018-000042_bb0185","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13059-015-0620-6","article-title":"Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy","volume":"16","author":"Angelova","year":"2015","journal-title":"Genome Biol"},{"key":"10.1136\/ijgc-2018-000042_bb0190","first-page":"5564","article-title":"Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability","volume":"63","author":"Ishikawa","year":"2003","journal-title":"Cancer Res"},{"key":"10.1136\/ijgc-2018-000042_bb0195","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1158\/1055-9965.EPI-14-0654","article-title":"Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer type","volume":"23","author":"Gatalica","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1136\/ijgc-2018-000042_bb0200","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0002-9440(10)65436-3","article-title":"High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability","volume":"154","author":"Dolcetti","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1136\/ijgc-2018-000042_bb0205","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24010284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24010284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2018-000042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:23:25Z","timestamp":1753233805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24010284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1048891X24010284"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2018-000042","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic characteristics, tumor infiltrating lymphocytes and programed cell death ligand-1 expression in 162 endometrial carcinomas with deficient mismatch repair function","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2018-000042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}